Daniel has 20 years of experience in large company and startup environments across medical devices and biotech. As a Director at Broadview Ventures, Daniel focuses on new investment activity and portfolio management within Broadview’s MedTech practice, long-term portfolio strategy, and Broadview investment operations and organizational growth.
Daniel’s experience includes operational roles in marketing and strategy, corporate and business development, and corporate venture capital. Previously, Daniel was Vice President of Corporate Development at Proteon Therapeutics, leading business development, strategic marketing, and corporate development activities from pre-IND through Phase 3 clinical studies. Prior to Proteon, Daniel held marketing roles at Abbott Vascular and Guidant and was a member of Guidant Compass, the company’s corporate venture capital, business development, and corporate strategy group, where he led early-stage investments in coronary and peripheral revascularization, cardiac rhythm management, heart failure monitoring, and cardiac surgery.
Daniel holds a BA from the University of Pennsylvania and an MBA from the Tuck School of Business at Dartmouth College.